Clinical chemistry cost per reportable result
Ended Awarded Last action
- Contract number
- HT940626FE026
- Awardee
-
Roche Diagnostics S.P.A. UEI CRBLKCZC9XC6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $42,378
Award facts
- Contract value 100% obligated
- $42,377.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Italy
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Roche Diagnostics S.P.A. on March 1, 2026, with a ceiling value of $42,377.73 for clinical chemistry cost per reportable result. Place of performance is Italy, with an ultimate completion date of September 30, 2026. Pricing is firm fixed price.
Quick answers
Who was awarded contract HT940626FE026?
HT940626FE026 was awarded to Roche Diagnostics S.P.A. by Defense Health Agency (Department of Defense) on March 1, 2026.
How much is contract HT940626FE026 worth?
The government has obligated $42,378 on HT940626FE026.
Is contract HT940626FE026 an order under another contract?
Yes. HT940626FE026 is a delivery order under W9114F26DA005, an indefinite delivery contract.
Was contract HT940626FE026 competed?
The extent of competition for HT940626FE026 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award